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ABSTRAK
Hiperkalemia ringan selalunya tidak menyebabkan gejala yang melibatkan jantung. 
Akan tetapi bagi pesakit tua yang menggunakan ubat penghalang atrio-ventrikular 
(AV), hiperkalemia ringan sekalipun boleh membawa musibah. Kami melaporkan 
satu kes bradiarithmia berpanjangan disebabkan hiperkalemia iatrogenik pada 
seorang pesakit yang menggunakan ubatan penghalang AV. Seorang wanita 
berusia 81 tahun yang mengambil pelbagai ubatan kerana beberapa masalah 
perubatan telah datang dengan gejala bradiarithmia. Malah beliau mempunyai 
dua jenis ubat preskripsi penghalang AV yang berbeza iaitu penghalang beta dan 
amiodaron. Tahap potassium beliau agak tinggi sedikit disebabkan kerosakan 
buah pinggang akut. Gejala bradikardia beliau berterusan dan beliau bergantung 
kepada ubat isoproterenol sehingga fungsi buah pinggang kembali normal. Kes ini 
menekankan paras yang berbeza untuk manifestasi gejala hiperkalemia berlaku 
kepada kumpulan pesakit yang semakin ramai: pesakit tua yang mempunyai 
pelbagai masalah kesihatan dan polifarmasi.
Kata kunci: bradiarithmia, bradikardia, orang tua, hiperkalemia, polifarmasi
ABSTRACT
Mild hyperkalaemia does not typically cause cardiac symptoms. However, for an 
elderly patient on atrio-ventricular (AV) nodal blocker, even mild hyperkalaemia 
may result in disastrous outcome. We report a case of persistent bradyarrythmia 
caused by iatrogenic hyperkalaemia in a patient who had concomitant use of AV 
nodal medication. An 81-year-old lady with multiple comorbidities and a long list 
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of medications presented with symptomatic bradyarrhythmia. She, in fact, had 
two AV nodal blockers in her prescription, a beta-blocker and amiodarone. Her 
potassium level was found to be mildly elevated due to acute renal failure. She 
remained bradycardic despite initial treatment and was subsequently dependant 
on intravenous isoproterenol until her renal function improved. This case highlights 
the different threshold for manifestation of hyperkalaemic symptoms in a growing 
group of patients: elderly patients with multiple comorbidities and polypharmacy.
Keywords: bradyarrythmia, bradycardia, elderly, hyperkalaemia, polypharmacy
blood pressure of 165/74mmHg but 
bradycardic with heart rate of 33 beats/
min. Other vital signs were within 
normal range. Physical examinations 
were unremarkable.  
 Electrocardiogram (ECG) on arrival 
showed absence of P wave with slow 
ventricular rate (Figure 1). Her renal 
profile was deranged with potassium 
of 5.8 mmol/l, urea of 29.4mmol/l and 
creatinine of 272 mmol/l. Meanwhile, 
her international normalized ratio (INR) 
was 3.2 and her activated prothrombin 
time (aPTT) was 69.2. Her full blood 
count (FBC), electrolytes and cardiac 
enzymes were within normal range.
 There was limited information 
regarding her baseline medical 
condition. It was known that her past 
medical illnesses include diabetes 
mellitus, hypertension, dyslipidaemia, 
ischaemic heart disease as well as 
atrial fibrillation for which she was 
under follow up by a private centre 
elsewhere. She was on a number of oral 
medications that included bisoprolol, 
amiodarone, rivaroxaban, ezetimibe, 
amlodipine, spironolactone, slow K 
and subcutaneous insulin. She was 
unsure regarding the duration that she 
has had the medications for.
INTRODUCTION
Hyperkalaemia is a condition where 
the serum level of potassium is elevated 
due to various factors. Potassium affects 
the generation of action potential in 
myocardial tissue where at a higher 
level may cause atrial and ventricular 
arrhythmias including heart blocks and 
asystole. Serum level above 5.0 mmol/L 
is considered as hyperkalaemia. 
Typically mild elevation between 5.1 
to 6.0mmol/L does not usually cause 
any cardiac symptoms. However, 
mild hyperkalaemia in the setting of 
concomitant use of atrio-ventricular 
(AV) nodal blocker may be hazardous 
for a patient, especially in the elderly 
population.
CASE REPORT
An 81-year-old lady presented to the 
Emergency Cardiac Assessment Unit 
of a specialized Cardiac Centre with 
2 days history of chest discomfort 
over central chest which was 
associated with giddiness and lethargy. 
Otherwise, she denied having chest 
pain, breathlessness or palpitation. She 
was mildly hypertensive on arrival with 
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 Intravenous atropine 0.5mg was 
given twice (total of 1mg) to no 
effect. She was started on intravenous 
isoproterenol infusion and was 
monitored in the Coronary Care 
Unit (CCU). Echocardiogram (ECHO) 
showed good cardiac function with 
no obvious regional wall motion 
abnormalities. In the ward, her 
potassium level normalized following 
gradual improvement of her kidney 
function without requiring dialysis. 
She was dependant on intravenous 
isoproterenol infusion to maintain her 
heart rate above 40 beats/min (Figure 
2) for about 2 weeks.
 Her persistent bradycardia was 
attributed to beta blocker and 
amiodarone overdose. She was 
initially planned for temporary 
pacemaker insertion. However, after 
the improvement of her renal function, 
her heart rate remained within the 
normal range without isoproterenol 
support (Figure 3).
DISCUSSION
The percentage of elderly population 
above the age of 65 yrs has increased 
in the past few years and it is estimated 
to reach 1.2 billion in 2025. A shift 
in focus of health-care and medical 
needs to cater for this population 
essentially aligns with the demographic 
transformation (Puska & Kalache 2013). 
Elderly patients are particularly at risk 
of drug-drug interaction as they are 
typically ardent user of medications. In 
addition, their age-related physiological 
changes further influences individual 
drug effects (Lee et al. 2011). This case 
report highlighted the diagnosis and 
challenges encountered in managing 
an elderly patient with bradyarrhythmia 
due to effect of iatrogenic mild 
hyperkalaemia with concomitant use 
of multiple AV blockers.
 Drug-induced hyperkalaemia is 
a significant health-care concern as 
it reflects the failure of managing 
Figure 1: Initial electrocardiogram (ECG) during arrival to the emergency cardiac unit showing no P 
wave and slow ventricular rate of 33 beats per minute.
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polypharmacy, which is seen more 
commonly in geriatric population due 
to multiple co-morbidities. Numerous 
factors may lead to the occurrence of 
iatrogenic hyperkalaemia in elderly 
including age-related decline in 
glomerular filtration rate, volume 
depletion of various causes, use 
of certain medications linked to 
diseases such as diabetes mellitus, 
cardiovascular disease or renal 
disorders as well as from overzealous 
potassium diets (Aziz et al. 2011). 
Elderly population is also more prone 
to hospital admissions. It was noted 
that there was a significant increase 
in the number of potential drug-
drug interaction from admission to 
discharge and hyperkalaemia was the 
most prevalent potential adverse effect 
Figure 2: Electrocardiogram (ECG) on day 7, whilst on intravenous isoprenaline infusion 60mcg per 
ml per hour. There is absent of P wave and ventricular rate of 50 beats per minute.   
Figure 3: Electrocardiogram prior to patient discharge, showing atrial fibrillation with left axis 
deviation. The ventricular rate documented on the ECG was 73 beats per minute.
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observed (Straubhaar et al. 2006). This 
finding is parallel with another study 
that found 85% of patients treated with 
numerous cardiovascular diseases 
medications in outpatient setting have 
elevated renal function parameters 
upon their admission to hospital 
(Wozakowska-Kaplon & Janowska-
Molenda 2009).
 Elevation of potassium level on 
its own can provoke arrhythmia and 
heart blocks through its effects on 
the myocardial tissue irrespective of 
the degree of increment from normal 
level. Even mild hyperkalaemia 
may precipitate underlying cardiac 
conduction disturbances leading to 
severe bradyarrhythmias (Palmisano 
et al. 2014). In a small study of 26 
patients, 81% of patients with mild to 
moderate hyperkalaemia presented 
with complete heart block with half 
of them requiring temporary pacing 
(Aziz et al. 2011). A study on seasonal 
distribution incidence of severe 
life-threatening bradyarrhythmias 
requiring temporary cardiac pacing in 
elderly noted that there is a significant 
increase in the number of patients 
in the hottest months of the year 
(Palmisano et al. 2014). Apart from 
the risk acquired from several types of 
medications that predispose to renal 
failure or those with potassium sparing 
mechanism, elderly in Malaysia are 
constantly susceptible to dehydration 
and intravascular volume depletion 
attributable to Malaysia’s hot and 
humid weather.
 An interesting article summarizes the 
relationship between renal failure with 
hyperkalaemia and bradycardia with 
concomitant use of atrio-ventricular 
(AV) node blocker by defining the 
combination as BRASH syndrome 
(a mnemonic for bradycardia, renal 
failure, AV node blocker, shock and 
hyperkalaemia) (Farkas 2016). The 
main pathophysiologic key of BRASH 
syndrome is said to be the synergistic 
effect of hyperkalaemia caused by 
renal failure with AV node blockers 
to cause bradycardia (Farkas 2016; 
Hegazi et al. 2012). Bradycardia will 
subsequently lead to hypoperfusion 
that in turn worsens the renal failure and 
eventually perpetuates a vicious cycle. 
This syndrome may occur in the setting 
of mild hyperkalaemia along with ECG 
findings of bradycardia in the absence 
of other features of hyperkalaemia, 
differentiating it from bradycardia 
caused solely by hyperkalaemia. 
On the other hand, the features that 
differentiate BRASH syndrome from 
AV node blocker overdose alone is the 
presence of hyperkalaemia which is 
not typically present and the absence 
of history suggesting drug overdose 
(Farkas 2016).
 The occurrence of bradyarrhythmias 
in this patient may be explained by 
the presence of multiple elements. 
Each factor may not be independent 
of one another. Instead, they correlate 
to establish an entity that is new and 
under-recognized. Nevertheless, it 
is essential to recognize the risk for 
bradyarrhythmias in patients on AV 
blocker in the setting of acute renal 
failure with even mild hyperkalaemia.
CONCLUSION
In an elderly patient with polypharmacy, 
bradyarrhythmias may develop due to 
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even mild iatrogenic hyperkalaemia 
caused by acute renal failure when 
there is concurrent use of AV nodal 
medications.
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